The University of Chicago Header Logo

Connection

Robert Naclerio to Humans

Back to Details
This is a "connection" page, showing publications Robert Naclerio has written about Humans.
Robert Naclerio
Connection Strength
1.567
Humans
  1. Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP). J Allergy Clin Immunol Pract. 2024 Apr; 12(4):1062-1064.
    View in: PubMed
    Score: 0.030
  2. A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012-2022. J Allergy Clin Immunol Pract. 2023 01; 11(1):43-50.
    View in: PubMed
    Score: 0.028
  3. Management of the Upper Airway Distress During Pregnancy. Immunol Allergy Clin North Am. 2023 02; 43(1):53-64.
    View in: PubMed
    Score: 0.028
  4. A modest proposal for a new way forward for clinical research: Involve insurance companies. Int Forum Allergy Rhinol. 2022 05; 12(5):685-689.
    View in: PubMed
    Score: 0.026
  5. The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 Era. J Allergy Clin Immunol Pract. 2020 09; 8(8):2492-2494.
    View in: PubMed
    Score: 0.023
  6. Sinonasal Disease: An Underappreciated Entity. J Allergy Clin Immunol Pract. 2020 05; 8(5):1567-1568.
    View in: PubMed
    Score: 0.023
  7. Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop. J Allergy Clin Immunol Pract. 2020 05; 8(5):1532-1549.e1.
    View in: PubMed
    Score: 0.023
  8. A Pragmatic Approach Towards Sinonasal Diseases. J Allergy Clin Immunol Pract. 2020 05; 8(5):1556-1558.
    View in: PubMed
    Score: 0.023
  9. Persistence of Sinonasal Disease Despite Mepolizumab. J Allergy Clin Immunol Pract. 2020 05; 8(5):1550-1555.
    View in: PubMed
    Score: 0.023
  10. Uncharted Waters: Challenges in the Era of Biologic Therapies for Nasal Polyposis. J Allergy Clin Immunol Pract. 2019 01; 7(1):68-70.
    View in: PubMed
    Score: 0.021
  11. Nasal Polyps and Biomarkers. J Allergy Clin Immunol Pract. 2017 Nov - Dec; 5(6):1589-1590.
    View in: PubMed
    Score: 0.020
  12. Choice of Analgesics After Adenotonsillectomy: Are We Between a Rock and a Hard Place? JAMA Otolaryngol Head Neck Surg. 2016 11 01; 142(11):1041-1042.
    View in: PubMed
    Score: 0.018
  13. Other Phenotypes and Treatment of Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):613-20.
    View in: PubMed
    Score: 0.018
  14. A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
    View in: PubMed
    Score: 0.018
  15. A Rapidly Enlarging Forehead Mass in a Young Retinoblastoma Survivor. JAMA Otolaryngol Head Neck Surg. 2016 06 01; 142(6):597-8.
    View in: PubMed
    Score: 0.018
  16. Radiologic Findings in Allergic Fungal Rhinosinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):749-50.
    View in: PubMed
    Score: 0.018
  17. Progressive unilateral nasal congestion, facial pain, and vision change in an immunocompetent patient. JAMA Otolaryngol Head Neck Surg. 2015 Jun; 141(6):579-80.
    View in: PubMed
    Score: 0.017
  18. Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review. Int Forum Allergy Rhinol. 2015 Jul; 5(7):590-6.
    View in: PubMed
    Score: 0.016
  19. Drowning in applications for residency training: a program's perspective and simple solutions. JAMA Otolaryngol Head Neck Surg. 2014 Aug; 140(8):695-6.
    View in: PubMed
    Score: 0.016
  20. Evidence-based approach to medical and surgical treatment of nasal polyposis. J Allergy Clin Immunol. 2013 Dec; 132(6):1461-1462.e3.
    View in: PubMed
    Score: 0.015
  21. No difference in blood loss during endoscopic sinus surgery with total intravenous anesthesia--reply. JAMA Otolaryngol Head Neck Surg. 2013 Oct; 139(10):1077-8.
    View in: PubMed
    Score: 0.015
  22. Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
    View in: PubMed
    Score: 0.015
  23. Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
    View in: PubMed
    Score: 0.014
  24. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
    View in: PubMed
    Score: 0.014
  25. Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
    View in: PubMed
    Score: 0.013
  26. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
    View in: PubMed
    Score: 0.012
  27. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
    View in: PubMed
    Score: 0.012
  28. Introduction: insights into the upper airway for pulmonologists and allergists. Proc Am Thorac Soc. 2011 Mar; 8(1):30.
    View in: PubMed
    Score: 0.012
  29. Anatomy and physiology of the upper airway. Proc Am Thorac Soc. 2011 Mar; 8(1):31-9.
    View in: PubMed
    Score: 0.012
  30. Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper. Allergy Asthma Proc. 2011 Mar-Apr; 32(2):168-77.
    View in: PubMed
    Score: 0.012
  31. Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
    View in: PubMed
    Score: 0.012
  32. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
    View in: PubMed
    Score: 0.012
  33. Calcified maxillary cyst secondary to a foreign-body reaction at the site of a remote tooth extraction. Ear Nose Throat J. 2010 Jan; 89(1):42-3.
    View in: PubMed
    Score: 0.011
  34. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
    View in: PubMed
    Score: 0.011
  35. Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? Allergy Asthma Proc. 2009 Mar-Apr; 30(2):212-3; author reply 213-4.
    View in: PubMed
    Score: 0.011
  36. Otolaryngology (urban) legend: the more programs to which you apply, the better the chances of matching. Arch Otolaryngol Head Neck Surg. 2008 Oct; 134(10):1038.
    View in: PubMed
    Score: 0.010
  37. Effect of changing airway pressure on the ability of the human nose to warm and humidify air. Ann Otol Rhinol Laryngol. 2008 Jul; 117(7):501-5.
    View in: PubMed
    Score: 0.010
  38. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol. 2008 Aug; 122(2):415-7.
    View in: PubMed
    Score: 0.010
  39. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
    View in: PubMed
    Score: 0.010
  40. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.010
  41. Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis. Otolaryngol Head Neck Surg. 2008 Feb; 138(2):129-39.
    View in: PubMed
    Score: 0.010
  42. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
    View in: PubMed
    Score: 0.010
  43. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed. 2007 Aug 15; 9(3):35.
    View in: PubMed
    Score: 0.010
  44. Familial aggregation of nasal conditioning capacity. J Appl Physiol (1985). 2007 Sep; 103(3):1078-81.
    View in: PubMed
    Score: 0.010
  45. Observations on the ability of the nose to warm and humidify inspired air. Rhinology. 2007 Jun; 45(2):102-11.
    View in: PubMed
    Score: 0.009
  46. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
    View in: PubMed
    Score: 0.009
  47. Cold air-induced rhinitis. Clin Allergy Immunol. 2007; 19:267-81.
    View in: PubMed
    Score: 0.009
  48. Environmental and allergic factors in chronic rhinosinusitis. Clin Allergy Immunol. 2007; 20:25-49.
    View in: PubMed
    Score: 0.009
  49. Effects of saline sprays on symptoms after endoscopic sinus surgery. Am J Rhinol. 2006 Mar-Apr; 20(2):191-6.
    View in: PubMed
    Score: 0.009
  50. Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
    View in: PubMed
    Score: 0.009
  51. Alpha-adrenoreceptor blockade with phenoxybenzamine does not affect the ability of the nose to condition air. J Appl Physiol (1985). 2005 Jul; 99(1):128-33.
    View in: PubMed
    Score: 0.008
  52. Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
    View in: PubMed
    Score: 0.008
  53. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review. Curr Med Res Opin. 2024 Aug; 40(8):1297-1309.
    View in: PubMed
    Score: 0.008
  54. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
    View in: PubMed
    Score: 0.008
  55. Role of allergy in rhinosinusitis. Curr Opin Allergy Clin Immunol. 2004 Feb; 4(1):17-23.
    View in: PubMed
    Score: 0.008
  56. Elevation of the nasal mucosal surface temperature after warming of the feet occurs via a neural reflex. Acta Otolaryngol. 2003 Jun; 123(5):627-36.
    View in: PubMed
    Score: 0.007
  57. Radiology quiz case 2. Verrucous carcinoma of the maxillary antrum. Arch Otolaryngol Head Neck Surg. 2003 Feb; 129(2):259, 260-1.
    View in: PubMed
    Score: 0.007
  58. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg. 2003 Feb; 128(2):220-7.
    View in: PubMed
    Score: 0.007
  59. Pathology quiz case 2. Extranodal natural killer (NK)/T-cell lymphoma (Epstein-Barr virus associated). Arch Otolaryngol Head Neck Surg. 2002 Nov; 128(11):1327, 1328-9.
    View in: PubMed
    Score: 0.007
  60. Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis. Am J Rhinol Allergy. 2022 Nov; 36(6):733-740.
    View in: PubMed
    Score: 0.007
  61. Antiallergic anti-inflammatory effects of H1-antihistamines in humans. Clin Allergy Immunol. 2002; 17:101-39.
    View in: PubMed
    Score: 0.007
  62. Supine position decreases the ability of the nose to warm and humidify air. J Appl Physiol (1985). 2001 Dec; 91(6):2459-65.
    View in: PubMed
    Score: 0.006
  63. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
    View in: PubMed
    Score: 0.006
  64. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
    View in: PubMed
    Score: 0.006
  65. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
    View in: PubMed
    Score: 0.006
  66. Complications of nasal SARS-CoV-2 testing: a review. J Investig Med. 2021 12; 69(8):1399-1403.
    View in: PubMed
    Score: 0.006
  67. Chronic Rhinosinusitis of Odontogenic Origin. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2894-2895.
    View in: PubMed
    Score: 0.006
  68. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus. Allergy. 2021 08; 76(8):2354-2366.
    View in: PubMed
    Score: 0.006
  69. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021 08; 76(8):2337-2353.
    View in: PubMed
    Score: 0.006
  70. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
    View in: PubMed
    Score: 0.006
  71. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 03; 11(3):213-739.
    View in: PubMed
    Score: 0.006
  72. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.006
  73. Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex. J Allergy Clin Immunol. 2001 Jan; 107(1):194-5.
    View in: PubMed
    Score: 0.006
  74. Elevation of nasal mucosal temperature increases the ability of the nose to warm and humidify air. Am J Rhinol. 2001 Jan-Feb; 15(1):41-5.
    View in: PubMed
    Score: 0.006
  75. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
    View in: PubMed
    Score: 0.006
  76. Unusual presentation of a rare nasal tumor. Otolaryngol Head Neck Surg. 2000 Dec; 123(6):746-7.
    View in: PubMed
    Score: 0.006
  77. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice. Allergy. 2021 01; 76(1):168-190.
    View in: PubMed
    Score: 0.006
  78. Dose-dependent effects of intranasal steroids: how relevant? Ann Allergy Asthma Immunol. 2000 Oct; 85(4):248-9.
    View in: PubMed
    Score: 0.006
  79. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy. 2020 10; 75(10):2440-2444.
    View in: PubMed
    Score: 0.006
  80. Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
    View in: PubMed
    Score: 0.006
  81. Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. Allergy. 2020 07; 75(7):1546-1554.
    View in: PubMed
    Score: 0.006
  82. Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
    View in: PubMed
    Score: 0.006
  83. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
    View in: PubMed
    Score: 0.006
  84. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 01; 58(1):10-17.
    View in: PubMed
    Score: 0.006
  85. Antiallergic effects of H1-receptor antagonists. Allergy. 2000; 55 Suppl 64:17-27.
    View in: PubMed
    Score: 0.006
  86. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
    View in: PubMed
    Score: 0.006
  87. Comparison of the response to histamine challenge of the nose and the maxillary sinus: effect of loratadine. J Appl Physiol (1985). 1999 Sep; 87(3):1038-47.
    View in: PubMed
    Score: 0.006
  88. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
    View in: PubMed
    Score: 0.006
  89. A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol (1985). 1999 Jul; 87(1):400-6.
    View in: PubMed
    Score: 0.005
  90. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy": AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project. Allergy. 2019 07; 74(7):1219-1236.
    View in: PubMed
    Score: 0.005
  91. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.005
  92. Clinical manifestations of the release of histamine and other inflammatory mediators. J Allergy Clin Immunol. 1999 Mar; 103(3 Pt 2):S382-5.
    View in: PubMed
    Score: 0.005
  93. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
    View in: PubMed
    Score: 0.005
  94. Multiple myeloma presenting as proptosis. Ann Otol Rhinol Laryngol. 1999 Feb; 108(2):211-3.
    View in: PubMed
    Score: 0.005
  95. Optimizing treatment options. Clin Exp Allergy. 1998 Dec; 28 Suppl 6:54-9.
    View in: PubMed
    Score: 0.005
  96. A mouse model of acute bacterial rhinosinusitis. Arch Otolaryngol Head Neck Surg. 1998 Nov; 124(11):1227-32.
    View in: PubMed
    Score: 0.005
  97. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019 03; 143(3):864-879.
    View in: PubMed
    Score: 0.005
  98. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.005
  99. Understanding the inflammatory processes in upper allergic airway disease and asthma. J Allergy Clin Immunol. 1998 Feb; 101(2 Pt 2):S345-51.
    View in: PubMed
    Score: 0.005
  100. Rhinitis and inhalant allergens. JAMA. 1997 Dec 10; 278(22):1842-8.
    View in: PubMed
    Score: 0.005
  101. Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
    View in: PubMed
    Score: 0.005
  102. Total IgE serum levels correlate with sinus mucosal thickness on computerized tomography scans. J Allergy Clin Immunol. 1997 Oct; 100(4):563-8.
    View in: PubMed
    Score: 0.005
  103. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
    View in: PubMed
    Score: 0.005
  104. Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
    View in: PubMed
    Score: 0.005
  105. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
    View in: PubMed
    Score: 0.005
  106. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
    View in: PubMed
    Score: 0.005
  107. Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
    View in: PubMed
    Score: 0.005
  108. Pathophysiology of perennial allergic rhinitis. Allergy. 1997; 52(36 Suppl):7-13.
    View in: PubMed
    Score: 0.005
  109. Allergy and asthma medication use in home-dwelling U.S. older adults. Int Forum Allergy Rhinol. 2017 02; 7(2):192-198.
    View in: PubMed
    Score: 0.005
  110. Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
    View in: PubMed
    Score: 0.005
  111. Development of a hypoplastic maxillary sinus. Ann Otol Rhinol Laryngol. 1996 Apr; 105(4):327-8.
    View in: PubMed
    Score: 0.004
  112. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
    View in: PubMed
    Score: 0.004
  113. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
    View in: PubMed
    Score: 0.004
  114. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016 Feb 02; 315(5):469-79.
    View in: PubMed
    Score: 0.004
  115. Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
    View in: PubMed
    Score: 0.004
  116. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016 Feb; 6 Suppl 1:S22-209.
    View in: PubMed
    Score: 0.004
  117. Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg. 1995 Dec; 121(12):1396-402.
    View in: PubMed
    Score: 0.004
  118. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy. 2015 Nov; 70(11):1372-92.
    View in: PubMed
    Score: 0.004
  119. Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
    View in: PubMed
    Score: 0.004
  120. Local nasal immunotherapy. Has the time come? Am J Respir Crit Care Med. 1995 Aug; 152(2):425-6.
    View in: PubMed
    Score: 0.004
  121. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.004
  122. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
    View in: PubMed
    Score: 0.004
  123. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
    View in: PubMed
    Score: 0.004
  124. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
    View in: PubMed
    Score: 0.004
  125. Unilateral choanal atresia masquerading as chronic sinusitis. Pediatrics. 1994 Dec; 94(6 Pt 1):941-4.
    View in: PubMed
    Score: 0.004
  126. Observations on the response of the nasal mucosa to allergens. Otolaryngol Head Neck Surg. 1994 Sep; 111(3 Pt 2):355-63.
    View in: PubMed
    Score: 0.004
  127. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
    View in: PubMed
    Score: 0.004
  128. Prelaminated fascia lata free flap for large nasal septal defect reconstruction. J Plast Reconstr Aesthet Surg. 2014 Oct; 67(10):1440-3.
    View in: PubMed
    Score: 0.004
  129. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
    View in: PubMed
    Score: 0.004
  130. Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Aug; 4(8):609-16.
    View in: PubMed
    Score: 0.004
  131. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.004
  132. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
    View in: PubMed
    Score: 0.004
  133. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
    View in: PubMed
    Score: 0.004
  134. A pilot study of the effects of intranasal budesonide delivered by NasoNeb® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.004
  135. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
    View in: PubMed
    Score: 0.004
  136. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
    View in: PubMed
    Score: 0.004
  137. Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
    View in: PubMed
    Score: 0.004
  138. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
    View in: PubMed
    Score: 0.004
  139. Coronal CT scan abnormalities in children with chronic sinusitis. Laryngoscope. 1993 Sep; 103(9):985-90.
    View in: PubMed
    Score: 0.004
  140. Immunologic changes after nasal provocation with allergen. Otolaryngol Head Neck Surg. 1993 Sep; 109(3 Pt 2):579-83.
    View in: PubMed
    Score: 0.004
  141. Inflammatory diseases of the sinuses: an overview of immunology. Otolaryngol Clin North Am. 1993 Aug; 26(4):571-91.
    View in: PubMed
    Score: 0.004
  142. Advertisements impact the physiological efficacy of a branded drug. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):12931-5.
    View in: PubMed
    Score: 0.004
  143. The effect of antihistamines on the immediate allergic response: a comparative review. Otolaryngol Head Neck Surg. 1993 Jun; 108(6):723-30.
    View in: PubMed
    Score: 0.004
  144. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol (1985). 1993 Jun; 74(6):2661-71.
    View in: PubMed
    Score: 0.004
  145. Blood loss during endoscopic sinus surgery with propofol or sevoflurane: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2013 May; 139(5):510-4.
    View in: PubMed
    Score: 0.004
  146. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013 Jun; 131(6):1479-90.
    View in: PubMed
    Score: 0.004
  147. Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response. PLoS One. 2013; 8(2):e57566.
    View in: PubMed
    Score: 0.004
  148. Dual function of novel pollen coat (surface) proteins: IgE-binding capacity and proteolytic activity disrupting the airway epithelial barrier. PLoS One. 2013; 8(1):e53337.
    View in: PubMed
    Score: 0.003
  149. Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol. 1993; 101(3):311-7.
    View in: PubMed
    Score: 0.003
  150. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol. 1992 Dec; 90(6 Pt 2):1051-4.
    View in: PubMed
    Score: 0.003
  151. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012 Nov; 130(5):1049-62.
    View in: PubMed
    Score: 0.003
  152. Inhibition of mediator release during the early reaction to antigen. J Allergy Clin Immunol. 1992 Oct; 90(4 Pt 2):715-9.
    View in: PubMed
    Score: 0.003
  153. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012 Sep-Oct; 33 Suppl 1:S113-41.
    View in: PubMed
    Score: 0.003
  154. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 1):373-6.
    View in: PubMed
    Score: 0.003
  155. Anatomic and physiologic considerations in sinusitis. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 2):419-23.
    View in: PubMed
    Score: 0.003
  156. Complications of sinusitis. J Allergy Clin Immunol. 1992 Sep; 90(3 Pt 2):552-4.
    View in: PubMed
    Score: 0.003
  157. Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis. Am J Rhinol Allergy. 2012 Sep-Oct; 26(5):371-9.
    View in: PubMed
    Score: 0.003
  158. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.003
  159. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
    View in: PubMed
    Score: 0.003
  160. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
    View in: PubMed
    Score: 0.003
  161. Environmental influence: potential interactions. Otolaryngol Head Neck Surg. 1992 Jun; 106(6):660-4.
    View in: PubMed
    Score: 0.003
  162. Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning. Laryngoscope. 1992 Mar; 102(3):330-4.
    View in: PubMed
    Score: 0.003
  163. Tympanostomy tube insertion: anterosuperior vs. anteroinferior quadrant. Otolaryngol Head Neck Surg. 1992 Mar; 106(3):241-2.
    View in: PubMed
    Score: 0.003
  164. The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
    View in: PubMed
    Score: 0.003
  165. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol. 2012; 158(3):216-31.
    View in: PubMed
    Score: 0.003
  166. Fireside conference 7. Immunotherapy for allergic rhinitis. Rhinol Suppl. 1992; 14:209-12.
    View in: PubMed
    Score: 0.003
  167. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
    View in: PubMed
    Score: 0.003
  168. Airways, allergy, sinus. Otolaryngol Head Neck Surg. 1992 Jan; 106(1):20.
    View in: PubMed
    Score: 0.003
  169. Allergic rhinitis. N Engl J Med. 1991 Sep 19; 325(12):860-9.
    View in: PubMed
    Score: 0.003
  170. Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
    View in: PubMed
    Score: 0.003
  171. Microbiology of chronic sinusitis in children. Arch Otolaryngol Head Neck Surg. 1991 Sep; 117(9):980-3.
    View in: PubMed
    Score: 0.003
  172. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991 Jul; 88(1):27-32.
    View in: PubMed
    Score: 0.003
  173. Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
    View in: PubMed
    Score: 0.003
  174. The nasal allergic reaction: observations on the role of histamine. Clin Exp Allergy. 1991 May; 21 Suppl 2:13-9.
    View in: PubMed
    Score: 0.003
  175. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis. 1991 May; 143(5 Pt 2):S91-5.
    View in: PubMed
    Score: 0.003
  176. The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
    View in: PubMed
    Score: 0.003
  177. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.003
  178. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
    View in: PubMed
    Score: 0.003
  179. Phenol as an adjuvant anesthetic for tympanostomy tube insertion. Int J Pediatr Otorhinolaryngol. 1991 Feb; 21(1):51-8.
    View in: PubMed
    Score: 0.003
  180. Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness. Int Arch Allergy Appl Immunol. 1991; 95(2-3):149-55.
    View in: PubMed
    Score: 0.003
  181. Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
    View in: PubMed
    Score: 0.003
  182. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol. 1990 Dec; 86(6 Pt 1):851-61.
    View in: PubMed
    Score: 0.003
  183. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
    View in: PubMed
    Score: 0.003
  184. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
    View in: PubMed
    Score: 0.003
  185. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy. 2010 Oct; 65(10):1212-21.
    View in: PubMed
    Score: 0.003
  186. The role of histamine in allergic rhinitis. J Allergy Clin Immunol. 1990 Oct; 86(4 Pt 2):628-32.
    View in: PubMed
    Score: 0.003
  187. Vitamin D levels in children undergoing adenotonsillectomies. Int J Pediatr Otorhinolaryngol. 2010 Sep; 74(9):1075-7.
    View in: PubMed
    Score: 0.003
  188. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
    View in: PubMed
    Score: 0.003
  189. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
    View in: PubMed
    Score: 0.003
  190. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):155-61.
    View in: PubMed
    Score: 0.003
  191. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
    View in: PubMed
    Score: 0.003
  192. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
    View in: PubMed
    Score: 0.003
  193. Decrease in xenon clearance during response to cold, dry air: problems of interpretation. Ann Otol Rhinol Laryngol. 1990 Feb; 99(2 Pt 1):155-9.
    View in: PubMed
    Score: 0.003
  194. The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test. Am J Rhinol Allergy. 2010 Jan-Feb; 24(1):34-8.
    View in: PubMed
    Score: 0.003
  195. The effects of H1 antihistamines on the early allergic response. Ann Allergy. 1989 Dec; 63(6 Pt 2):551-5.
    View in: PubMed
    Score: 0.003
  196. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009 Nov; 121(6):121-39.
    View in: PubMed
    Score: 0.003
  197. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
    View in: PubMed
    Score: 0.003
  198. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989 Oct; 84(4 Pt 1):492-501.
    View in: PubMed
    Score: 0.003
  199. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol. 1989 Sep; 84(3):338-46.
    View in: PubMed
    Score: 0.003
  200. Criteria to screen for chronic sinonasal disease. Chest. 2009 Nov; 136(5):1324-1332.
    View in: PubMed
    Score: 0.003
  201. The effect of cetirizine on early allergic response. Laryngoscope. 1989 Jun; 99(6 Pt 1):596-9.
    View in: PubMed
    Score: 0.003
  202. Recent studies on the rule of kinins in inflammatory diseases of human airways. Adv Exp Med Biol. 1989; 247A:117-23.
    View in: PubMed
    Score: 0.003
  203. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope. 2008 Nov; 118(11):2067-72.
    View in: PubMed
    Score: 0.003
  204. The pathophysiology of allergic rhinitis: impact of therapeutic intervention. J Allergy Clin Immunol. 1988 Nov; 82(5 Pt 2):927-34.
    View in: PubMed
    Score: 0.003
  205. Nasal challenge with cold, dry air induces a late-phase reaction. Am Rev Respir Dis. 1988 Aug; 138(2):400-5.
    View in: PubMed
    Score: 0.003
  206. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988 Aug; 138(2):406-12.
    View in: PubMed
    Score: 0.003
  207. Experimentally induced nasal allergic responses. J Allergy Clin Immunol. 1988 May; 81(5 Pt 2):940-9.
    View in: PubMed
    Score: 0.003
  208. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008 Apr; 63 Suppl 86:8-160.
    View in: PubMed
    Score: 0.003
  209. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
    View in: PubMed
    Score: 0.002
  210. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
    View in: PubMed
    Score: 0.002
  211. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J. 1988 Mar; 7(3):218-22.
    View in: PubMed
    Score: 0.002
  212. A genome-wide screen for hyposmia susceptibility Loci. Chem Senses. 2008 Apr; 33(4):319-29.
    View in: PubMed
    Score: 0.002
  213. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan; 157(1):133-42.
    View in: PubMed
    Score: 0.002
  214. Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007 Nov-Dec; 10(6):457-65.
    View in: PubMed
    Score: 0.002
  215. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
    View in: PubMed
    Score: 0.002
  216. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.002
  217. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
    View in: PubMed
    Score: 0.002
  218. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987 Apr; 79(4):599-604.
    View in: PubMed
    Score: 0.002
  219. Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
    View in: PubMed
    Score: 0.002
  220. Observations on nasal late phase reactions. Immunol Invest. 1987-1988 Dec; 16(8):649-85.
    View in: PubMed
    Score: 0.002
  221. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):874-6.
    View in: PubMed
    Score: 0.002
  222. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986 Nov; 134(5):1102.
    View in: PubMed
    Score: 0.002
  223. Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006 Nov; 135(5 Suppl):S31-80.
    View in: PubMed
    Score: 0.002
  224. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006 Nov; 118(5 Suppl):S17-61.
    View in: PubMed
    Score: 0.002
  225. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy. 2006 Sep; 61(9):1086-96.
    View in: PubMed
    Score: 0.002
  226. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
    View in: PubMed
    Score: 0.002
  227. The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
    View in: PubMed
    Score: 0.002
  228. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.002
  229. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
    View in: PubMed
    Score: 0.002
  230. Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
    View in: PubMed
    Score: 0.002
  231. Recent advances in immunology with specific reference to otolaryngology. Otolaryngol Clin North Am. 1985 Nov; 18(4):821-32.
    View in: PubMed
    Score: 0.002
  232. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.002
  233. Osteoblastoma of the temporal bone presenting as facial paralysis. Int J Pediatr Otorhinolaryngol. 1985 Mar; 8(3):253-62.
    View in: PubMed
    Score: 0.002
  234. Effect of seasonal ragweed exposure on immunoglobulin E antiragweed antibodies in cultures of peripheral mononuclear cells, plasma and nasal secretions. Int Arch Allergy Appl Immunol. 1985; 78(3):225-32.
    View in: PubMed
    Score: 0.002
  235. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004 Dec; 131(6 Suppl):S1-62.
    View in: PubMed
    Score: 0.002
  236. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004 Dec; 114(6 Suppl):155-212.
    View in: PubMed
    Score: 0.002
  237. In vivo model for the evaluation of topical antiallergic medications. Arch Otolaryngol. 1984 Jan; 110(1):25-7.
    View in: PubMed
    Score: 0.002
  238. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
    View in: PubMed
    Score: 0.002
  239. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
    View in: PubMed
    Score: 0.002
  240. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
    View in: PubMed
    Score: 0.002
  241. Immunologic observations during desensitization and maintenance of clinical tolerance to penicillin. J Allergy Clin Immunol. 1983 Mar; 71(3):294-301.
    View in: PubMed
    Score: 0.002
  242. Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA). Allergy. 2003 Mar; 58(3):192-7.
    View in: PubMed
    Score: 0.002
  243. In vivo demonstration of inflammatory mediator release following nasal challenge with antigen. Eur J Respir Dis Suppl. 1983; 128 (Pt 1):26-32.
    View in: PubMed
    Score: 0.002
  244. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.002
  245. Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
    View in: PubMed
    Score: 0.002
  246. A retrospective analysis of the intact canal wall tympanoplasty with mastoidectomy. Am J Otol. 1981 Apr; 2(4):315-7.
    View in: PubMed
    Score: 0.002
  247. Pathologic quiz case 1. Arch Otolaryngol. 1980 Aug; 106(8):514-6.
    View in: PubMed
    Score: 0.001
  248. Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):741-8.
    View in: PubMed
    Score: 0.001
  249. Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):585-90.
    View in: PubMed
    Score: 0.001
  250. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.001
  251. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol. 1997 Jun; 99(6 Pt 3):S829-48.
    View in: PubMed
    Score: 0.001
  252. Sinusitis: bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg. 1997 Jun; 116(6 Pt 2):S1-20.
    View in: PubMed
    Score: 0.001
  253. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
    View in: PubMed
    Score: 0.001
  254. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther. 1997; 10(2):97-104.
    View in: PubMed
    Score: 0.001
  255. CD4+ lymphocytes are increased in the sinus mucosa of children with chronic sinusitis. Arch Otolaryngol Head Neck Surg. 1996 Oct; 122(10):1071-6.
    View in: PubMed
    Score: 0.001
  256. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
    View in: PubMed
    Score: 0.001
  257. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1006-16.
    View in: PubMed
    Score: 0.001
  258. The human nasal response to capsaicin. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1035-45.
    View in: PubMed
    Score: 0.001
  259. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
    View in: PubMed
    Score: 0.001
  260. Bilateral maxillary sinus mucoceles in an infant with cystic fibrosis. Otolaryngol Head Neck Surg. 1994 Jul; 111(1):116-20.
    View in: PubMed
    Score: 0.001
  261. Reflex activation of nasal secretion by unilateral inhalation of cold dry air. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1616-22.
    View in: PubMed
    Score: 0.001
  262. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg. 1992 Sep; 118(9):940-3.
    View in: PubMed
    Score: 0.001
  263. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
    View in: PubMed
    Score: 0.001
  264. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
    View in: PubMed
    Score: 0.001
  265. Quantitative IgE- and IgG-subclass responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol. 1992 Feb; 89(2):519-29.
    View in: PubMed
    Score: 0.001
  266. Preinduction of anesthesia in children with rectally administered midazolam. Anesthesiology. 1991 Apr; 74(4):670-4.
    View in: PubMed
    Score: 0.001
  267. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
    View in: PubMed
    Score: 0.001
  268. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol. 1991; 95(4):322-31.
    View in: PubMed
    Score: 0.001
  269. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990 Nov; 162(5):1173-7.
    View in: PubMed
    Score: 0.001
  270. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis. 1990 Sep; 142(3):594-601.
    View in: PubMed
    Score: 0.001
  271. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
    View in: PubMed
    Score: 0.001
  272. Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
    View in: PubMed
    Score: 0.001
  273. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen. Int Arch Allergy Appl Immunol. 1990; 93(2-3):165-70.
    View in: PubMed
    Score: 0.001
  274. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990 Jan; 161(1):120-3.
    View in: PubMed
    Score: 0.001
  275. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.001
  276. Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
    View in: PubMed
    Score: 0.001
  277. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.001
  278. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
    View in: PubMed
    Score: 0.001
  279. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
    View in: PubMed
    Score: 0.001
  280. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar; 81(3):580-9.
    View in: PubMed
    Score: 0.001
  281. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy. 1987 Oct; 42(7):496-501.
    View in: PubMed
    Score: 0.001
  282. Endoscopic middle meatal antrostomy: theory, technique, and patency. Laryngoscope. 1987 Aug; 97(8 Pt 3 Suppl 43):1-9.
    View in: PubMed
    Score: 0.001
  283. Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. J Immunol. 1987 Jul 15; 139(2):506-12.
    View in: PubMed
    Score: 0.001
  284. Is leukotriene B4 an important mediator in human IgE-mediated allergic reactions? Am Rev Respir Dis. 1987 Jun; 135(6 Pt 2):S42-5.
    View in: PubMed
    Score: 0.001
  285. The pathophysiology of human mast cells. In vitro and in vivo function. Am Rev Respir Dis. 1987 May; 135(5):1196-200.
    View in: PubMed
    Score: 0.001
  286. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol. 1987 Jan 15; 138(2):428-34.
    View in: PubMed
    Score: 0.001
  287. Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol. 1987; 82(3-4):493-7.
    View in: PubMed
    Score: 0.001
  288. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.001
  289. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
    View in: PubMed
    Score: 0.001
  290. Local generation of sulfidopeptide leukotrienes upon nasal provocation with cold, dry air. Am Rev Respir Dis. 1986 Jun; 133(6):1133-7.
    View in: PubMed
    Score: 0.001
  291. The role of kinins in human allergic disease. N Engl Reg Allergy Proc. 1986 May-Jun; 7(3):213-8.
    View in: PubMed
    Score: 0.001
  292. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
    View in: PubMed
    Score: 0.001
  293. Kininogens in nasal secretions after allergen challenge. Adv Exp Med Biol. 1986; 198 Pt B:189-92.
    View in: PubMed
    Score: 0.001
  294. The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
    View in: PubMed
    Score: 0.001
  295. Kinins as mediators of human allergic reactions. Adv Exp Med Biol. 1986; 198 Pt B:181-7.
    View in: PubMed
    Score: 0.001
  296. Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis. Am J Med. 1985 Dec 20; 79(6A):26-33.
    View in: PubMed
    Score: 0.001
  297. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
    View in: PubMed
    Score: 0.001
  298. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.001
  299. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
    View in: PubMed
    Score: 0.001
  300. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
    View in: PubMed
    Score: 0.001
  301. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.001
  302. Mast cells and mast cell mediators in models of airway disease. Prog Clin Biol Res. 1985; 199:153-61.
    View in: PubMed
    Score: 0.001
  303. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 1):473-81.
    View in: PubMed
    Score: 0.000
  304. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
    View in: PubMed
    Score: 0.000
  305. IgE-mediated leukotriene release in vitro and in vivo. Trans Assoc Am Physicians. 1984; 97:260-7.
    View in: PubMed
    Score: 0.000
  306. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.000
  307. The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians. 1982; 95:221-8.
    View in: PubMed
    Score: 0.000
  308. Radiographic staging of juvenile angiofibroma. Head Neck Surg. 1981 Mar-Apr; 3(4):279-83.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.